1-octadec-9-enoylglycero-3-phosphate multiple interactions ISO RGD:1342753 6480464 lysophosphatidic acid promotes the reaction [[KITLG protein co-treated with EPO protein] results in increased expression of GYPA mRNA] CTD PMID:21915944 17alpha-ethynylestradiol multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of GYPA mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of GYPA mRNA CTD PMID:17942748 aflatoxin B1 decreases methylation ISO RGD:1342753 6480464 Aflatoxin B1 results in decreased methylation of GYPA gene CTD PMID:27153756 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO RGD:1342753 6480464 pyrazolanthrone inhibits the reaction [Tetradecanoylphorbol Acetate results in decreased expression of GYPA protein] CTD PMID:20523355 apigenin increases expression ISO RGD:1342753 6480464 Apigenin results in increased expression of GYPA protein CTD PMID:25058688 apigenin 7-O-beta-D-glucoside increases expression ISO RGD:1342753 6480464 apigetrin results in increased expression of GYPA protein CTD PMID:25058688 apocynin multiple interactions ISO RGD:1342753 6480464 acetovanillone inhibits the reaction [Tetradecanoylphorbol Acetate results in decreased expression of GYPA protein] CTD PMID:20523355 arsane decreases expression EXP 6480464 Arsenic results in decreased expression of GYPA mRNA CTD PMID:19654921 arsane increases mutagenesis ISO RGD:1342753 6480464 Arsenic results in increased mutagenesis of GYPA gene CTD PMID:17029826 arsenic atom decreases expression EXP 6480464 Arsenic results in decreased expression of GYPA mRNA CTD PMID:19654921 arsenic atom increases mutagenesis ISO RGD:1342753 6480464 Arsenic results in increased mutagenesis of GYPA gene CTD PMID:17029826 arsenous acid decreases expression ISO RGD:1342753 6480464 Arsenic Trioxide results in decreased expression of GYPA protein CTD PMID:16360329 benzene-1,2,4-triol decreases expression ISO RGD:1342753 6480464 hydroxyhydroquinone results in decreased expression of GYPA protein CTD PMID:21414390 benzo[a]pyrene decreases expression EXP 6480464 Benzoapyrene results in decreased expression of GYPA mRNA CTD PMID:17942131 buta-1,3-diene increases expression EXP 6480464 1, 3-butadiene results in increased expression of GYPA mRNA CTD PMID:29038090 butyric acid multiple interactions ISO RGD:1342753 6480464 tellimagrandin I inhibits the reaction [Butyric Acid results in increased expression of GYPA protein] CTD PMID:14757314 butyric acid increases expression ISO RGD:1342753 6480464 Butyric Acid results in increased expression of GYPA protein CTD PMID:14757314 capsaicin increases expression EXP 6480464 Capsaicin results in increased expression of GYPA mRNA CTD PMID:17603282 Chebulinic acid multiple interactions ISO RGD:1342753 6480464 chebulinic acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of GYPA protein] CTD PMID:14769215 cobalt dichloride decreases expression ISO RGD:1342753 6480464 cobaltous chloride results in decreased expression of GYPA mRNA CTD PMID:22941251 cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of GYPA mRNA CTD PMID:17942131 cytidine multiple interactions ISO RGD:1342753 6480464 Cytidine inhibits the reaction [A 771726 results in increased expression of GYPA protein] CTD PMID:12181422 diarsenic trioxide decreases expression ISO RGD:1342753 6480464 Arsenic Trioxide results in decreased expression of GYPA protein CTD PMID:16360329 dibenziodolium multiple interactions ISO RGD:1342753 6480464 diphenyleneiodonium inhibits the reaction [Tetradecanoylphorbol Acetate results in decreased expression of GYPA protein] CTD PMID:20523355 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of GYPA mRNA CTD PMID:21266533 dihydroartemisinin affects expression ISO RGD:1342753 6480464 dihydroartemisinin affects the expression of GYPA protein CTD PMID:20688127 GTP increases expression ISO RGD:1342753 6480464 Guanosine Triphosphate results in increased expression of GYPA protein CTD PMID:17002868 hydroquinone decreases expression ISO RGD:1342753 6480464 hydroquinone results in decreased expression of GYPA protein CTD PMID:21414390 lamivudine multiple interactions ISO RGD:1342753 6480464 [Zidovudine co-treated with Lamivudine] results in increased mutagenesis of GYPA gene CTD PMID:17358027 LY294002 multiple interactions ISO RGD:1342753 6480464 2-4-morpholinyl-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Tetradecanoylphorbol Acetate results in decreased expression of GYPA protein] CTD PMID:20523355 midostaurin decreases expression ISO RGD:1342753 6480464 midostaurin results in decreased expression of GYPA protein CTD PMID:19573588 N-acetyl-L-cysteine multiple interactions ISO RGD:1342753 6480464 Acetylcysteine inhibits the reaction [Tetradecanoylphorbol Acetate results in decreased expression of GYPA protein] CTD PMID:20523355 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of GYPA mRNA CTD PMID:17942131 phorbol 13-acetate 12-myristate decreases expression ISO RGD:1342753 6480464 Tetradecanoylphorbol Acetate results in decreased expression of GYPA protein CTD PMID:20523355 phorbol 13-acetate 12-myristate increases expression ISO RGD:1342753 6480464 Tetradecanoylphorbol Acetate results in increased expression of GYPA protein CTD PMID:14769215 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:1342753 6480464 10-4'-N-diethylaminobutyl-2-chlorophenoxazine inhibits the reaction [Tetradecanoylphorbol Acetate results in decreased expression of GYPA protein] more ... CTD PMID:14769215 , PMID:20523355 potassium dichromate decreases expression EXP 6480464 Potassium Dichromate results in decreased expression of GYPA mRNA CTD PMID:23608068 quercetin multiple interactions ISO RGD:1342753 6480464 Quercetin inhibits the reaction [Tetradecanoylphorbol Acetate results in decreased expression of GYPA protein] CTD PMID:20523355 resveratrol increases expression ISO RGD:1342753 6480464 resveratrol results in increased expression of GYPA mRNA, resveratrol results in increased expression of GYPA protein CTD PMID:24526417 Tellimagrandin I decreases expression ISO RGD:1342753 6480464 tellimagrandin I results in decreased expression of GYPA protein CTD PMID:14757314 Tellimagrandin I multiple interactions ISO RGD:1342753 6480464 tellimagrandin I inhibits the reaction [Butyric Acid results in increased expression of GYPA protein] CTD PMID:14757314 teriflunomide multiple interactions ISO RGD:1342753 6480464 Cytidine inhibits the reaction [A 771726 results in increased expression of GYPA protein], Uridine inhibits the reaction [A 771726 results in increased expression of GYPA protein] CTD PMID:12181422 teriflunomide increases expression ISO RGD:1342753 6480464 A 771726 results in increased expression of GYPA protein CTD PMID:12181422 tremolite asbestos increases expression EXP 6480464 tremolite results in increased expression of GYPA mRNA CTD PMID:29279043 Tributyltin oxide decreases expression EXP 6480464 bistri-n-butyltinoxide results in decreased expression of GYPA mRNA CTD PMID:17942131 tungsten decreases expression EXP 6480464 Tungsten results in decreased expression of GYPA mRNA CTD PMID:30912803 uridine multiple interactions ISO RGD:1342753 6480464 Uridine inhibits the reaction [A 771726 results in increased expression of GYPA protein] CTD PMID:12181422 zidovudine multiple interactions ISO RGD:1342753 6480464 [Zidovudine co-treated with Lamivudine] results in increased mutagenesis of GYPA gene CTD PMID:17358027 zinc atom decreases expression ISO RGD:1342753 6480464 Zinc deficiency results in decreased expression of GYPA mRNA CTD PMID:18356318 zinc(0) decreases expression ISO RGD:1342753 6480464 Zinc deficiency results in decreased expression of GYPA mRNA CTD PMID:18356318